ArticleBiomedicines2023

Association between Biomarkers (VEGF-R2, VEGF-R3, VCAM-1) and Treatment Duration in Patients with Neuroendocrine Tumors Receiving Therapy with First-Generation Somatostatin Analogues.

Violetta Rosiek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.